ArticleJournal of virology2020
Impact of T
Open access · hybridAbstract read
In one paragraph
Article in Journal of virology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.
0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 39 citations in OpenAlex.
- Rapid and robust immune response boosting with potent, next-generation adjuvant in viral vector-primed primates.Journal of virology · 2026Article
- Coadministration of rapamycin with a DNA/MVA SIV vaccine improves memory CD8+ T cell response.JCI insight · 2026Article
- α4 Integrin blockade impairs CD8+ T cell neuroimmune surveillance following SIV infection.The Journal of clinical investigation · 2026Article
- ALFQ adjuvanted HIV-1 envelope protein vaccination elicits durable functional antibody and cellular responses in nonhuman primates.NPJ vaccines · 2025Article
- Modeling the Synergetic Dynamics of B cells and TbioRxiv : the preprint server for biology · 2025Article
- HIV vaccine candidate ΔV1gp120 formulated in ALFQA adjuvant augments mucosal immunity in female macaques.Nature communications · 2025Article
- Article
- Article
- Transient pain and long-term gain: adjuvant dose directs immune memory.The Journal of clinical investigation · 2025Article
- Generation of antigen-specific memory CD4 T cells by heterologous immunization enhances the magnitude of the germinal center response upon influenza infection.PLoS pathogens · 2024Article
- Chronic SIV-Induced neuroinflammation disrupts CCR7+ CD4+ T cell immunosurveillance in the rhesus macaque brain.The Journal of clinical investigation · 2024Article
- Tailoring TeLife · 2024Article
- Deep analysis of CD4 T cells in the rhesus CNS during SIV infection.PLoS pathogens · 2023Article
- ALVAC-HIV and AIDSVAX B/E vaccination induce improved immune responses compared with AIDSVAX B/E vaccination alone.JCI insight · 2023Article
- SARS-CoV-2 spike-ferritin-nanoparticle adjuvanted with ALFQ induces long-lived plasma cells and cross-neutralizing antibodies.NPJ vaccines · 2023Article
- Differences in HPV-specific antibody Fc-effector functions following Gardasil® and Cervarix® vaccination.NPJ vaccines · 2023Article
- Cholera toxin B scaffolded, focused SIV V2 epitope elicits antibodies that influence the risk of SIVFrontiers in immunology · 2023Article
- Neuroinflammatory transcriptional programs induced in rhesus pre-frontal cortex white matter during acute SHIV infection.Journal of neuroinflammation · 2022Article
- Designing spatial and temporal control of vaccine responses.Nature reviews. Materials · 2022Review
- Adults with Plasmodium falciparum malaria have higher magnitude and quality of circulating T-follicular helper cells compared to children.EBioMedicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors at 9 institutions in 1 country.
Anil Verma *The Center for Immunology and Infectious Diseases, UC Davis, Davis, California, USA.
Brian A Schmidt *The Center for Immunology and Infectious Diseases, UC Davis, Davis, California, USA.
Sonny R ElizaldiThe Center for Immunology and Infectious Diseases, UC Davis, Davis, California, USA.
Nancy K NguyenThe Center for Immunology and Infectious Diseases, UC Davis, Davis, California, USA.
Korey A WalterDepartment of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.
Zoltan BeckHenry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA.
Hung V TrinhHenry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA.ORCID 0000-0001-8014-9291
Ashok R DinasarapuEmory Department of Human Genetics, Emory University, Atlanta, Georgia, USA.
Yashavanth Shaan LakshmanappaThe Center for Immunology and Infectious Diseases, UC Davis, Davis, California, USA.
Niharika N RaneThe Center for Immunology and Infectious Diseases, UC Davis, Davis, California, USA.
Gary R MatyasU.S. Military HIV Research Program, Laboratory of Adjuvant and Antigen Research, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Mangala RaoU.S. Military HIV Research Program, Laboratory of Adjuvant and Antigen Research, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Xiaoying ShenDuke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA.ORCID 0000-0002-8387-3952
Georgia D TomarasDuke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA.ORCID 0000-0001-8076-1931
Celia C LaBrancheDuke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA.ORCID 0000-0002-6653-6655
Keith A ReimannNonhuman Primate Reagent Resource, MassBiologics, University of Massachusetts Medical School, Boston, Massachusetts, USA.
David H FoehlNonhuman Primate Reagent Resource, MassBiologics, University of Massachusetts Medical School, Boston, Massachusetts, USA.
Johannes S GachDivision of Infectious Diseases, Department of Medicine, University of California, Irvine, School of Medicine, UC Irvine, Irvine, California, USA.
Donald N ForthalDivision of Infectious Diseases, Department of Medicine, University of California, Irvine, School of Medicine, UC Irvine, Irvine, California, USA.
Pamela A KozlowskiDepartment of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.
Rama R AmaraDepartment of Microbiology and Immunology, Emory University, Atlanta, Georgia, USA.
Smita S IyerThe Center for Immunology and Infectious Diseases, UC Davis, Davis, California, USA smiyer@ucdavis.edu.
University of California, Davis · USDuke Medical Center · USEmory University · USHenry M. Jackson Foundation · USLouisiana State University Health Sciences Center New Orleans · USUniversity of California, Irvine · USUniversity of Massachusetts Chan Medical School · USWalter Reed Army Institute of Research · USDuke University · US
Funding
National Institute on Aging (NIA) ColonyP51OD011107 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Simon J. Atkinson · 2012 to 2026
$191.5MSocial and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI Nwora Lance Okeke · 2005 to 2026
$50.5MNonhuman Primate Reagent ResourceU24AI126683 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Diogo Magnani · 2016 to 2026
$20.1MTargeting CD4 TFH cells to enhance HIV vaccine-induced humoral immunityK01OD023034 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI IYER, SWAMINATHAN SMITA · 2016 to 2018
$1.0MRole of female genital mucosa associated CD4 T cells in vaccine-induced HIV susceptibilityR21AI143454 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI IYER, SWAMINATHAN SMITA · 2019 to 2020
$623kRole of vaginal microbiome and metabolome in HIV vaccine efficacyR03AI138792 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI IYER, SWAMINATHAN SMITA · 2018 to 2019
$157kNIAID NIH HHS P30 AI064518NIAID NIH HHS R03 AI138792NIAID NIH HHS R21 AI143454NIAID NIH HHS U24 AI126683NIH HHS K01 OD023034NIH HHS P51 OD011107
Abstract
Generating durable humoral immunity through vaccination depends upon effective interactions of follicular helper T (T
Indexed as
Immunization, SecondaryAdjuvants, ImmunologicAIDS VaccinesAnimalsB-LymphocytesFemaleGerminal CenterHIV-1HIV AntibodiesHumansImmunoglobulin GLipid AMacaca mulattaSaponinsTh1 CellsAdjuvants, ImmunologicAIDS VaccinesHIV AntibodiesImmunoglobulin GLipid Amonophosphoryl lipid Asaponin QA-21V1SaponinsadjuvantantibodyCD4Tfhvaccine
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.